Login / Signup

Crizotinib in ROS1 and MET Deregulated NSCLC-Response.

Lorenza LandiRossella BrunoGabriella FontaniniFederico Cappuzzo
Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)
Keyphrases
  • advanced non small cell lung cancer
  • small cell lung cancer
  • cell death
  • dna damage
  • tyrosine kinase
  • epidermal growth factor receptor
  • reactive oxygen species